Food additive may prevent spread of deadly new avian flu

October 23, 2013, University of Illinois at Chicago

A common food additive can block a deadly new strain of avian influenza virus from infecting healthy cells, report researchers at the University of Illinois at Chicago College of Medicine in the online journal, PLOS ONE.

The compound, in wide use as a preservative, binds to a part of the flu that has never been targeted by any existing antiviral drug, raising hopes for its effectiveness against multi-drug-resistant flu viruses.

"The recent H7N9 outbreak in China this past March had a mortality rate of more than 20 percent," says Michael Caffrey, associate professor of biochemistry and molecular genetics at UIC. That strain, which is new, is already showing resistance to the majority of existing drugs used to treat it, Caffrey said. Preventing an outbreak that could lead to mass casualties would be difficult with the current arsenal.

"The need to develop new antiviral therapeutics now is crucial," he said.

Flu viruses enter host using a special protein called hemagglutinin, which acts as a "key" that opens receptors on the cell surface. If hemagglutinin is disabled, the virus is locked out and can't infect cells.

UIC researchers, led by Caffrey, found that the FDA-approved tert-butyl hydroquinone sticks to a specific region on the hemagglutinin molecule. The additive, he said, "attaches to the Achilles' heel of the virus—a loop-shaped portion of hemagglutinin necessary for binding to cells, making cell infection impossible."

The loop on the hemagglutinin molecule represents a new therapeutic target, since existing drugs don't go after it, Caffrey said.

"Any drugs that focus on the hemagglutinin loop would be totally novel to , and so resistance, if developed, would still be a long way off."

Caffrey and his colleagues were looking at a different class of viruses when the first outbreak of the H7N9 virus was reported in China last spring.

"Tert-butyl hydroquinone was known to have virus-blocking effects for H3 viruses," he said. "So when the H7N9 outbreak occurred, we thought we'd see if it had any effect on H7 ."

Using a novel technique, the researchers fused the hemagglutinin of the H7N9 virus to a less dangerous virus in order to study it safely. They found that tert-butyl hydroquinone was able to prevent the virus from infecting human lung cells in the lab.

The researchers are now looking for ways to enhance tert-butyl hydroquinone's ability to prevent infection. One way might be to add it to poultry feed. Keeping the virus from spreading in chickens could reduce the likelihood of it jumping to humans, Caffrey said. While the compound is used in a variety of foods as a preservative and stabilizer, questions remain regarding its safety if consumed in very high doses.

Explore further: Researchers discover a new way that influenza can infect cells

Related Stories

Researchers discover a new way that influenza can infect cells

September 23, 2013
Scientists at Fred Hutchinson Cancer Research Center have uncovered a new mechanism by which influenza can infect cells – a finding that ultimately may have implications for immunity against the flu.

Studies showing how bird flu viruses could adapt to humans offer surveillance and vaccine strategies

June 6, 2013
Bird flu viruses are potentially highly lethal and pose a global threat, but relatively little is known about why certain strains spread more easily to humans than others. Two studies published today in the journal Cell identify ...

Novel avian influenza A virus has potential for both virulence and transmissibility in humans

September 10, 2013
A new study has found that a novel avian-origin H7N9 influenza A virus, which has recently emerged in humans, attaches moderately or abundantly to the epithelium of both the upper and lower respiratory tracts. This pattern ...

Study puts troubling traits of H7N9 avian flu virus on display

July 10, 2013
The emerging H7N9 avian influenza virus responsible for at least 37 deaths in China has qualities that could potentially spark a global outbreak of flu, according to a new study published today (July 10, 2013) in the journal ...

Mutant version of H5N1 flu virus found to be more preferential to human infection

April 25, 2013
(Medical Xpress)—An international team of bio-researchers has found that a mutant strain of the H5N1 influenza virus (created in a lab) has a 200-fold preference for binding with receptors in human cells, over those found ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (2) Oct 23, 2013
The idea of adding it to chicken feed sounds just plain insane. I cannot think of a better way of developing a resistant strain of flu. Please reconsider.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.